Actively Recruiting
Comparing Two Pulse Field Ablation Systems for Treating Persistent Atrial Fibrillation A Randomized Trial
Led by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Updated on 2026-10-20
120
Participants Needed
1
Research Sites
143 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to compare the effectiveness of two pulse field ablation PFA systems, System A and System B, in treating patients with persistent, symptomatic atrial fibrillation who are undergoing their first catheter ablation. The study is a single-center, randomized clinical trial enrolling 120 patients, split evenly between the two treatment groups, to assess how well each system reduces the recurrence of atrial fibrillation and related arrhythmias. Participants will receive one of the two PFA treatments using different cardiac catheters, both commonly used in clinical practice. During the ablation procedure, an implantable cardiac monitor ICM will be placed under the skin to continuously track heart rhythm. The study will monitor and compare outcomes up to 36 months after treatment to evaluate the efficacy and safety of each system. Throughout the study, participants will attend follow-up visits including 12-lead ECGs, ICM interrogations, updates on any adverse events, and quality of life surveys. The main measure of success is the number of participants free from atrial fibrillation, atrial flutter, or atrial tachycardia recurrence at 12 months, with additional monitoring continuing through 36 months. The study duration for each participant includes both treatment and extended follow-up, ensuring thorough assessment of long-term outcomes.
CONDITIONS
Brief Title
Comparison of Two Pulse Field Ablation Systems for AF Ablation
Research Team
A
Amit Thosani, MD
C
Caitlin Phalunas, Lead CRC
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here